- Generic name
- Atenolol
- Strength
- 50 mg
- Dosage form
- Tablet
- Manufactured by
- Delta Pharma Limited
Bpnol Tablet
About Bpnol 50 mg Tablet
Bpnol comes as a tablet with 50 mg of Atenolol, from Delta Pharma Limited. Bpnol 50 mg is used in the management of high blood pressure, either alone or together with other blood pressure medicines.
There are 59 brands of Atenolol listed in Bangladesh. The lowest listed price is Betanol 25 mg Tablet at ৳ 0.45 per unit.
What is Bpnol 50 mg Tablet?
Bpnol comes as a tablet with 50 mg of Atenolol, from Delta Pharma Limited. Its active ingredient is Atenolol, a cardioselective beta-adrenoceptor blocking drug that acts mainly on the heart. That contains Atenolol, a type of medicine known as a beta-adrenoceptor blocking drug. The dose and duration are chosen by the doctor, who will also check pulse and blood pressure.
Uses of Bpnol
Bpnol 50 mg is used in the management of high blood pressure, either alone or together with other blood pressure medicines. Only a doctor can decide whether it suits a particular person. It is also used for the long-term management of angina pectoris, a type of chest pain. Your doctor will confirm whether this medicine is appropriate for your condition.
How to use Bpnol
Swallow the tablet as your doctor has instructed. Swallow the tablet with water. Bpnol is taken by mouth. Do not change the dose or stop the medicine on your own, because beta-blockers should not be stopped suddenly without medical advice. If you miss a dose, follow your doctor's or pharmacist's advice.
Side effects of Bpnol
As expected with any beta-blocker, bradycardia and hypotension occurred more commonly in investigations of acute myocardial infarction treatment. If you notice any unusual symptoms, contact your doctor promptly. In studies after acute myocardial infarction, bradycardia and hypotension were reported more commonly. Tell your doctor if any side effect bothers you or does not go away. Do not change or stop the medicine yourself; the doctor will decide what is needed.
Safety and precautions
Use with caution in impaired renal function and in peripheral arterial circulatory disorders. Bpnol 50 mg tablet is contraindicated in people with sinus bradycardia, heart block greater than first degree, cardiogenic shock, overt cardiac failure, or a history of hypersensitivity to Atenolol or any ingredient of the product. It is Pregnancy Category D, and caution is needed in nursing women because clinically significant bradycardia has been reported in breast-fed infants. Tell your doctor before starting Bpnol if you are pregnant, planning pregnancy or breastfeeding, or if you have kidney, heart or circulation problems.
Frequently asked questions
What is Bpnol used for?
Bpnol 50 mg is used in the management of high blood pressure, either alone or together with other blood pressure medicines. Only a doctor can decide whether it suits a particular person.
How do I use Bpnol correctly?
Swallow the tablet as your doctor has instructed. Swallow the tablet with water.
Can Bpnol cause side effects?
As expected with any beta-blocker, bradycardia and hypotension occurred more commonly in investigations of acute myocardial infarction treatment. If you notice any unusual symptoms, contact your doctor promptly.
Who should be careful with Bpnol?
Use with caution in impaired renal function and in peripheral arterial circulatory disorders. Bpnol 50 mg tablet is contraindicated in people with sinus bradycardia, heart block greater than first degree, cardiogenic shock, overt cardiac failure, or a history of hypersensitivity to Atenolol or any ingredient of the product.
Also available as
Indications
- In the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.
- For the long-term management of patients with angina pectoris.
- In the management of hemodynamically stable patients with defnite or suspected acute myocardial infarction to reduce cardiovascular mortality.
Pharmacology
Dosage & Administration
Angina Pectoris: The initial dose of Atenolol is 50 mg given as one tablet a day. If an optimal response is not achieved within one week, the dosage should be increased to Atenolol 100 mg given as one tablet a day. Some patients may require a dosage of 200 mg once a day for optimal effect. Twenty-four hour control with once daily dosing is achieved by giving doses larger than necessary to achieve an immediate maximum effect. The maximum early effect on exercise tolerance occurs with doses of 50 to 100 mg, but at these doses the effect at 24 hours is attenuated, averaging about 50% to 75% of that observed with once a day oral doses of 200 mg.
Acute Myocardial Infarction: In patients with definite or suspected acute myocardial infarction, treatment with Atenolol I.V. Injection should be initiated as soon as possible after the patient's arrival in the hospital and after eligibility is established. Treatment should begin with the intravenous administration of 5 mg Atenolol over 5 minutes followed by another 5 mg intravenous injection 10 minutes later. In patients who tolerate the full intravenous dose (10 mg), Atenolol Tablets 50 mg should be initiated 10 minutes after the last intravenous dose followed by another 50 mg oral dose 12 hours later. Thereafter, Atenolol can be given orally either 100 mg once daily or 50 mg twice a day for a further 6-9 days or until discharge from the hospital. If bradycardia or hypotension requiring treatment or any other untoward effects occur, Atenolol should be discontinued.
Interaction
- Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents. Patients treated with Atenolol plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension.
- Calcium channel blockers may also have an additive effect when given with Atenolol.
- Disopyramide is a Type I antiarrhythmic drug with potent negative inotropic and chronotropic effects. Disopyramide has been associated with severe bradycardia, asystole and heart failure when administered with beta blockers.
- Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with beta blockers.
- Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine. If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine. If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped.
- Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers.
- While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic. Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.
- Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia.
Contraindications
- Sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure.
- Those patients with a history of hypersensitivity to the atenolol or any of the drug product’s components.
Side Effects
- Hematologic: Agranulocytosis.
- Allergic: Fever, combined with aching and sore throat, laryngospasm, and respiratory distress.
- Central Nervous System: Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation of time and place; short term memory loss; emotional lability with slightly clouded sensorium; and, decreased performance on neuropsychometrics.
- Gastrointestinal: Mesenteric arterial thrombosis, ischemic colitis.
- Miscellaneous: There have been reports of skin rashes and/or dry eyes associated with the use of beta-adrenergic blocking drugs. Discontinuance of the drug should be considered if any such reaction is not otherwise explicable. Patients should be closely monitored following cessation of therapy.
- Other: Erythematous rash
Pregnancy & Lactation
Precautions & Warnings
Impaired Renal Function: The drug should be used with caution in patients with impaired renal function.
Geriatric Use:
- Hypertension and Angina Pectoris: Due to Coronary Atherosclerosis: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
- Acute Myocardial Infarction: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function.
Overdose Effects
Storage Conditions
Alternative brands of Atenolol
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.